Advancing patient care: Machine learning models for predicting grade 3+ toxicities in gynecologic cancer patients treated with HDR brachytherapy.
Journal:
PloS one
PMID:
40367095
Abstract
BACKGROUND: Gynecological cancers are among the most prevalent cancers in women worldwide. Brachytherapy, often used as a boost to external beam radiotherapy, is integral to treatment. Advances in computation, algorithms, and data availability have popularized the use of machine learning to predict patient outcomes. Recent studies have applied models such as logistic regression, support vector machines, and deep learning networks to predict specific toxicities in patients who have undergone brachytherapy.